Healthy life extension positioned as geroscience’s north star
Peer-Reviewed Publication
Updates every hour. Last Updated: 27-May-2026 05:15 ET (27-May-2026 09:15 GMT/UTC)
Paired Box 3 (PAX3) is a protein that plays a critical role in the formation of tissues and organs during embryonic development and can positively (and less frequently, negatively) regulate gene expression. While progress has been made to advance our understanding of this critical and multi-faceted protein, there is still much that is unknown about the mechanisms by which PAX3 controls such a wide array of key cellular functions.
In a new review in the journal Biomolecules, researchers report that PAX3 is essential for the development of nerves, muscles, and melanocytes in embryos, and also plays a role in maintaining adult tissues in stem cells. Additionally, in some cancers, such as some muscle tumors and melanoma, researchers found that PAX3 is present in abnormally high levels and promote tumor progression.
The postpartum period is one of the most challenging times for mothers of all backgrounds. In addition to providing 24-hour care for a newborn infant (and likely other members of the family) on limited, sporadic sleep, these individuals are recovering from childbirth. From c-sections and other surgical procedures to mastitis and UTI infections, new mothers face a myriad of health issues and complications in the weeks and months after delivery.
Add the transportation, childcare, and access barriers faced by many rural, minority and low-resource communities, and the challenges are amplified even further. Telehealth has emerged as an increasingly widespread strategy for mitigating these obstacles, particularly during and after the COVID-19 pandemic when health care systems were strained/disrupted and in-person care posed additional safety concerns for vulnerable populations.
Young children who attend nursery get sick more often than those who don’t, but they will go on to have fewer illnesses during early school years, finds a new review of evidence by a group of parent-scientists involving University College London (UCL) researchers.
Alumnus Dr David Stirling’s generous contribution will support Warwick to Set the Pace in health equity – ensuring people everywhere benefit from medical research breakthroughs.